Dr. Phillip Chung-Ming Yang, MD

Dr. Yang practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Yang's NPI, 1932249174, was assigned on February 7, 2007. Dr. Yang graduated from Yale School of Medicine in 1989. Dr. Yang's California license number on file is G73144.

Dr. Yang's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Yang's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Yang to 1 more hospital and 1 medical group, each named with a free account. Dr. Yang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yang is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Yang has a license on file in California.

Dmand AI lists aneurysm, atherosclerosis, atrial fibrillation and flutter, cardiac arrhythmia, chronic hypertension, congestive heart failure, coronary artery disease and heart attack among the conditions Dr. Yang treats.

CMS data shows 2,376 Medicare services from Dr. Yang across 14 procedure codes in 2024, for 1,759 Medicare patients. Medicare paid $113,520 for them.

CMS counts 1,759 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 658 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 59, with 49% women.

In 2024, Dr. Yang wrote 524 Medicare Part D claims for 83 patients. 88% of them were for generic drugs. CMS names the drug for 413 of them, across 13 drugs with 11 or more claims each, at $28,434 in total drug cost. In 2023, CMS named 300 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

Dmand AI links 159 papers to Dr. Yang, published from 2004 to 2025. 2016 was the busiest year, with 16. The most frequent topics are Magnetic Resonance Imaging, Myocardial Infarction and Myocardium. Dr. Yang has published most often in Magn Reson Med. Dr. Yang's most frequent co-authors are Michael Vincent C McConnell, MD, Roberto Bolli, MD and Bob Sueh-Chien Hu, MD.

Dmand AI links Dr. Yang to 10 clinical trials, 3 of them phase 2 studies. Conditions studied include Myocardial Infarction, Heart Failure and Ventricular Dysfunction, Left. Stanford University sponsors the most, 2.

CMS Open Payments shows 18 general payments to Dr. Yang from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Amgen Inc. paid the most, $7,140.

Dmand AI lists 3 awards for Dr. Yang, most recently CMS Stage 1 EHR in 2013.

Dr. Yang graduated from Yale School of Medicine in 1989. Dr. Yang is a member of ACC.

Dr. Yang is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.